Mazor Robotics (NASDAQ:MZOR) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Saturday.

Other equities analysts have also recently issued reports about the stock. ValuEngine raised shares of Mazor Robotics from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 8th. Zacks Investment Research cut shares of Mazor Robotics from a “hold” rating to a “sell” rating in a research note on Thursday, August 9th. Cantor Fitzgerald started coverage on shares of Mazor Robotics in a research note on Thursday, May 31st. They issued a “neutral” rating and a $57.00 price objective on the stock. Finally, Needham & Company LLC raised shares of Mazor Robotics from an “underperform” rating to a “hold” rating in a research note on Friday. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $61.08.

Shares of Mazor Robotics stock opened at $58.15 on Friday. The firm has a market capitalization of $1.53 billion, a PE ratio of -116.30 and a beta of 1.51. Mazor Robotics has a 12 month low of $41.60 and a 12 month high of $76.56.

Mazor Robotics (NASDAQ:MZOR) last announced its quarterly earnings data on Thursday, August 2nd. The medical instruments supplier reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.13). The firm had revenue of $13.20 million during the quarter, compared to analyst estimates of $17.02 million. Mazor Robotics had a negative net margin of 12.80% and a negative return on equity of 7.17%. The business’s quarterly revenue was down 14.8% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.05) earnings per share. analysts predict that Mazor Robotics will post -0.12 earnings per share for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in MZOR. Centaurus Financial Inc. purchased a new stake in shares of Mazor Robotics in the 2nd quarter worth about $139,000. Tower Research Capital LLC TRC purchased a new stake in shares of Mazor Robotics in the 2nd quarter worth about $203,000. Marshall Wace LLP purchased a new position in Mazor Robotics in the 2nd quarter valued at about $240,000. New England Research & Management Inc. purchased a new position in Mazor Robotics in the 2nd quarter valued at about $255,000. Finally, Alps Advisors Inc. purchased a new position in Mazor Robotics in the 2nd quarter valued at about $279,000. Institutional investors and hedge funds own 23.98% of the company’s stock.

About Mazor Robotics

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.

Read More: How Important is Technical Analysis of Stocks

Analyst Recommendations for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.